Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Blueprint Medicines Corp Stock

Price
Target price
€111.15

€111.15

-0.310%
-
-0.310%
-
 
29.07.25 / Tradegate WKN: A14SDD / Name: Blueprint / Stock / Biotechnology & Medical Research / Mid Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction
Pros and Cons of Blueprint Medicines Corp in the next few years
Wizard

Financial data and news for Blueprint

sharewise wants to provide you with the best news and tools for Blueprint, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

PEGA Surges 14%: There's Still Time to Ride This GenAI Innovator: https://www.marketbeat.com/logos/articles/med_20250725115155_pega-surges-14-theres-still-time-to-ride-this-gena.jpg
PEGA Surges 14%: There's Still Time to Ride This GenAI Innovator

For the second quarter in a row, artificial intelligence (AI) tech stock Pegasystems (NASDAQ: PEGA) crushed expectations.

Shares soared 14% on July 22 as the company eclipsed Wall Street

MarketBeat 
0 27.07.25
The Other AI Chipmaker: Why Marvell's Dip Is a Buy: https://www.marketbeat.com/logos/articles/med_20250611113504_the-other-ai-chipmaker-why-marvells-dip-is-a-buy.png
The Other AI Chipmaker: Why Marvell's Dip Is a Buy
[content-module:CompanyOverview|NASDAQ:MRVL]

In the race to power artificial intelligence (AI), some of the most essential players operate just outside the spotlight. Marvell Technology (NASDAQ:

MarketBeat 
0 12.06.25
Pegasystems: Mid-Cap GenAI Stock With Big Long-Term Potential
Pegasystems: Mid-Cap GenAI Stock With Big Long-Term Potential

Among the companies that have reported earnings so far in the Q1 2025 cycle, Pegasystems (NASDAQ: PEGA) is one that stands out. The AI stock popped by nearly 29% after its earnings release.

The

MarketBeat 
0 30.04.25
Blueprint Medicines Stock: Executives Sell Shares Amid Growth
Blueprint Medicines Stock: Executives Sell Shares Amid Growth

Blueprint Medicines, a biopharmaceutical company headquartered in Cambridge, Massachusetts, recently reported several significant stock transactions by its leadership team. Multiple executives sold

StockWorldEnglish 
0 08.03.25